The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period.

Horst Kokemueller, Majeed Rana, Jennifer Rublack, Andre Eckardt, Frank Tavassol, Paul Schumann, Daniel Lindhorst, Martin Ruecker, Nils-Claudius Gellrich
{"title":"The Hannover experience: surgical treatment of tongue cancer--a clinical retrospective evaluation over a 30 years period.","authors":"Horst Kokemueller,&nbsp;Majeed Rana,&nbsp;Jennifer Rublack,&nbsp;Andre Eckardt,&nbsp;Frank Tavassol,&nbsp;Paul Schumann,&nbsp;Daniel Lindhorst,&nbsp;Martin Ruecker,&nbsp;Nils-Claudius Gellrich","doi":"10.1186/1758-3284-3-27","DOIUrl":null,"url":null,"abstract":"<p><strong>Objectives: </strong>In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making.</p><p><strong>Materials and methods: </strong>Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation.</p><p><strong>Results: </strong>Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years.</p><p><strong>Conclusions: </strong>We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread.</p><p><strong>Clinical relevance: </strong>This study provides new treatment strategies for primary tumour disease and for tumour recurrence.</p>","PeriodicalId":49195,"journal":{"name":"Head and Neck Optical Diagnostics Society","volume":" ","pages":"27"},"PeriodicalIF":0.0000,"publicationDate":"2011-05-21","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/1758-3284-3-27","citationCount":"36","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Head and Neck Optical Diagnostics Society","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/1758-3284-3-27","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 36

Abstract

Objectives: In this retrospective study, we present a clinical review of our experience with tongue cancer in order to obtain valid criteria for therapeutic decision-making.

Materials and methods: Between 1980 and 2009, a total of 341 patients with squamous cell carcinoma of the tongue were treated at our Department. The average follow-up was 5.2 years. 309 patients received surgical treatment, which was combined in nearly 10% with neoadjuvant and in nearly 20% with postoperative radio(chemo)therapy. 32 patients were excluded from surgery and received primary radiation.

Results: Local and regional failure occurred in 23.9% and 20.4%, leading to a total failure rate of 37.2% after an average duration of 1,6 years. N-Status, extracapsular spread and clear margins were identified as the dominant factors for survival, which was calculated with 54.5% after 5 years.

Conclusions: We recommend categorical bilateral neck dissection in order to reliably remove occult lymph node metastases. Adjuvant treatment modalities should be applied more frequently in controlled clinical trials and should generally be implemented in cases with unclear margins and lymphatic spread.

Clinical relevance: This study provides new treatment strategies for primary tumour disease and for tumour recurrence.

Abstract Image

Abstract Image

Abstract Image

汉诺威经验:舌癌的手术治疗——30年的临床回顾性评估。
目的:在这项回顾性研究中,我们对舌癌的临床经验进行回顾,以获得有效的治疗决策标准。材料与方法:1980年至2009年,我科共收治舌鳞癌341例。平均随访时间为5.2年。309例患者接受手术治疗,其中近10%合并新辅助治疗,近20%合并术后放化疗。32例患者被排除在手术之外,接受了初级放疗。结果:局部失败率为23.9%,局部失败率为20.4%,平均持续时间为1.6年,总失败率为37.2%。n状态、囊外扩散和边缘清晰被认为是影响生存率的主要因素,5年后的生存率为54.5%。结论:我们推荐分型双侧颈部清扫术,以可靠地切除隐匿淋巴结转移。辅助治疗方式应在对照临床试验中更频繁地应用,通常应在边缘不清和淋巴扩散的病例中实施。临床意义:本研究为原发性肿瘤疾病和肿瘤复发提供了新的治疗策略。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信